Fig. 2From: The biology and role of CD44 in cancer progression: therapeutic implicationsMolecules regulate promoter activity and expression. a Several transcription factors including positive or negative regulators bind to the CD44 promoter region and regulate its activity. b Epithelial splicing regulatory protein 1 (ESRP1) is required for alternative splicing which generates different CD44 variant isoformsBack to article page